Navigation Links
Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign
Date:11/3/2008

BEDFORD, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the global leader in patch pump technology, and the International Diabetes Federation (IDF) today announced that Insulet is an official partner of IDF's World Diabetes Day (WDD) campaign. World Diabetes Day, celebrated on November 14, will raise awareness of children and adolescents with diabetes, spotlighting both the impact of the disease and access to care.

"Insulet's mission is to improve the lives of people with diabetes, so we felt it was imperative to join IDF to increase global awareness of this devastating disease, which affects millions of people worldwide," said Duane DeSisto, Insulet's president & chief executive officer. "Our easy-to-use OmniPod(R) Insulin Management System helps people with diabetes stay healthy while living life fully. OmniPod's innovative, tubing-free design provides all the benefits of pump therapy, which supplies the best control over diabetes, while eliminating the hassles of a traditional pump. Its virtually pain-free automated insertion has no needles in sight, which appeals to both children and adults. But primarily, OmniPod enables people with diabetes to simply live their lives normally."

The campaign also emphasizes that, with the right treatment, children and adolescents can live full, healthy and productive lives. To ensure this, it's vital that parents know the early warning signs of diabetes and if their child shows these signs, to seek immediate medical attention. These signs include:

-- Frequent urination

-- Excessive thirst

-- Increased hunger

-- Rapid weight loss

-- Tiredness

-- Lack of interest and concentration

-- Blurred vision

-- Vomiting and stomach pain (often mistaken as the flu)

"We are extremely pleased that Insulet is an official partner in World Diabetes Day and very much welcome their support and expertise in diabetes to bring attention to the disease," said World Diabetes Day Campaign Director Phil Riley.

Introduced by IDF and the World Health Organization in 1991, World Diabetes Day is celebrated every year on November 14 because it marks the birthday of Frederick Banting, who, along with Charles Best, is credited with the discovery of insulin. All WDD partners share the goal of increasing diabetes awareness, care and priority in the world health arena.

In addition to partnering in the WDD campaign, Insulet is focused on raising awareness of diabetes during November, National Diabetes Awareness Month, through a series of local market efforts in cities throughout the United States.

About Type 1 Diabetes

Type 1 diabetes is an autoimmune disease characterized by the destruction of more than 90% of the body's insulin-producing cells. It can neither be prevented nor cured. Globally, it is the most common form of diabetes in children, affecting around 500,000 children under 15, with 70,000 new cases diagnosed each year. Prevalence is increasing most quickly among pre-school children, at a rate of 5% per year.

About the International Diabetes Federation

The International Diabetes Federation (IDF) is an umbrella organization of over 200 member associations in more than 160 countries, advocating for the more than 250 million people with diabetes, their families, and their healthcare providers. Its mission is to promote diabetes care, prevention and a cure worldwide. The International Diabetes Federation is an NGO in official relations with the World Health Organization and an associated NGO with the United Nations Department of Public Information. The International Diabetes Federation leads the World Diabetes Day and Unite for Diabetes campaigns. Additional information is available at http://www.idf.org

About the OmniPod Insulin Management System

Cleared by the Food & Drug Administration (FDA) in January 2005, the OmniPod Insulin Management System offers people living with insulin-requiring diabetes unprecedented freedom, comfort and ease in managing their diabetes. The System currently consists of two devices, the compact, lightweight OmniPod, which is worn discreetly beneath clothing and delivers precise, personalized doses of insulin based on instructions programmed wirelessly using its companion, the handheld, wireless Personal Diabetes Manager (PDM). The OmniPod features no tubing and virtually pain-free automated insertion. The PDM, which is very similar in look and feel to a personal digital assistant, features an integrated blood glucose meter, disease management software and integrated storage and display of all insulin delivery, blood glucose and carbohydrate records.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-requiring diabetes. Founded in 2000, Insulet is based in Bedford, MA.

Contact:

Rachel Kessler, Lazar Partners

(917) 660-0608

Mark Sahl, Lazar Partners

(646) 871-8485


'/>"/>
SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. Insulet Corporation Announces Pricing of Secondary Public Offering
3. Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th
4. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
5. Insulet Corporation and DexCom Announce Development Agreement
6. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
7. Insulet Corporation to Present at the Canaccord Adams Diabetes & Obesity Conference on June 6, 2008
8. Insulet Announces Development Agreement for the First Non-Diabetes Drug Delivery Application for the OmniPod System
9. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
10. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
11. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... College District , the only authorized OSHA Training Institute Education Center headquartered in ... by protecting their workers from extreme heat at their worksites. Employers with ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/27/2016)... ... 27, 2016 , ... A revolution is underway. Brooklyn-based ... experience for the millions of people who require these medical transport services annually. ... through the use of technology. Now, SmartEMS has put forth an industry-changing app ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: